XML 49 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock Voting
Additional Paid In Capital
Accumulated Other Comprehensive Income (Loss)
Treasury stock
Retained Earnings
Beginning balance (in shares) at Mar. 31, 2018   117,744,913     37,474,890  
Beginning balance at Mar. 31, 2018 $ 2,068,782 $ 117 $ 2,665,120 $ 2,895 $ (995,843) $ 396,493
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (88,932)         (88,932)
Unrealized net investment gains 23     23    
Unrealized net gains (losses) on derivative financial instruments (214)     (214)    
Cumulative translation adjustments (2,149)     (2,149)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,183,380        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 27,217   27,217      
Issuance of common stock under employee stock purchase plan (in shares)   302,994        
Issuance of common stock under employee stock purchase plan 7,575   7,575      
Repurchase of treasury stock (in shares)         4,051,673  
Repurchase of treasury stock (9,855)   96,783   $ (106,638)  
Ending balance (in shares) at Sep. 30, 2018   119,231,287     41,526,563  
Ending balance at Sep. 30, 2018 2,036,598 $ 119 2,796,695 555 $ (1,102,481) 341,710
Beginning balance (in shares) at Jun. 30, 2018   118,139,282     37,604,005  
Beginning balance at Jun. 30, 2018 2,045,201 $ 117 2,676,382 (107) $ (999,329) 368,138
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (26,428)         (26,428)
Unrealized net investment gains (5)     (5)    
Unrealized net gains (losses) on derivative financial instruments 108     108    
Cumulative translation adjustments 559     559    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   789,011        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 15,955   15,955      
Issuance of common stock under employee stock purchase plan (in shares)   302,994        
Issuance of common stock under employee stock purchase plan 7,575   7,575      
Repurchase of treasury stock (in shares)         3,922,558  
Repurchase of treasury stock (6,369)   96,783   $ (103,152)  
Issuance of shares, net          
Ending balance (in shares) at Sep. 30, 2018   119,231,287     41,526,563  
Ending balance at Sep. 30, 2018 2,036,598 $ 119 2,796,695 555 $ (1,102,481) 341,710
Beginning balance (in shares) at Mar. 31, 2019   119,760,132     42,149,771  
Beginning balance at Mar. 31, 2019 2,065,433 $ 120 2,828,922 (2,639) $ (1,119,063) 358,093
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (46,815)         (46,815)
Unrealized net investment gains 37     37    
Unrealized net gains (losses) on derivative financial instruments (11)     (11)    
Cumulative translation adjustments (1,086)     (1,086)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,590,980        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 27,488   27,488      
Issuance of common stock under employee stock purchase plan (in shares)   297,635        
Issuance of common stock under employee stock purchase plan 6,593   6,593      
Repurchase of treasury stock (in shares)         4,660,929  
Repurchase of treasury stock (111,377)       $ (111,377)  
Ending balance (in shares) at Sep. 30, 2019   121,648,747     46,810,700  
Ending balance at Sep. 30, 2019 1,940,264 $ 122 2,863,003 (3,699) $ (1,230,440) 311,278
Beginning balance (in shares) at Jun. 30, 2019   120,123,018     43,568,720  
Beginning balance at Jun. 30, 2019 2,011,435 $ 120 2,841,001 (3,184) $ (1,155,252) 328,750
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (17,472)         (17,472)
Unrealized net investment gains 2     2    
Unrealized net gains (losses) on derivative financial instruments 8     8    
Cumulative translation adjustments (525)     (525)    
Issuance of common stock pursuant to vesting of restricted stock units (in shares)   1,228,094        
Issuance of common stock pursuant to vesting of restricted stock units 2 $ 2        
Stock-based compensation expense for restricted stock units granted to employees 15,409   15,409      
Issuance of common stock under employee stock purchase plan (in shares)   297,635        
Issuance of common stock under employee stock purchase plan 6,593   6,593      
Repurchase of treasury stock (in shares)         3,241,980  
Repurchase of treasury stock (75,188)       $ (75,188)  
Ending balance (in shares) at Sep. 30, 2019   121,648,747     46,810,700  
Ending balance at Sep. 30, 2019 $ 1,940,264 $ 122 $ 2,863,003 $ (3,699) $ (1,230,440) $ 311,278